News of the WeekGermany

Under Fire From Pharma, Institute May Lose Its Director

+ See all authors and affiliations

Science  22 Jan 2010:
Vol. 327, Issue 5964, pp. 402-403
DOI: 10.1126/science.327.5964.402-b

You are currently viewing the summary.

View Full Text

Summary

A long-running feud between pharmaceutical companies and the German institute that evaluates the effectiveness of medical treatments could cost the institute director his job. Although the post is supposed to be apolitical, members of Germany's new coalition government have called for Peter Sawicki, founding director of the Institute for Quality and Efficiency in Health Care, to be replaced with someone who is friendlier to the pharmaceutical industry. As Science went to press, the institute's board of directors was expected to decide on 20 January whether Sawicki, a clinical researcher and diabetes expert, will be replaced when his contract runs out later this year.